Courtney Lawrence: Targeted Donor Screening Reduces Transfusion-Transmitted Babesia Cases
Courtney Lawrence, Divisional Chief Medical Officer at the American Red Cross, shared a post on LinkedIn about a recent article by Rebecca Townsend et al, published in Transfusion:
“Interesting overview of 4 cases of transfusion-transmitted babesia, published in AABB Transfusion by the American Red Cross Scientific Office!
Targeted donor laboratory screening in babesia-endemic states has markedly decreased these reported cases.
This shows that informed testing strategies based off pretest probability can be highly effective, but continued transfusion surveillance is necessary to assess for existing gaps and develop potential improvements.
Congratulations to Dr Laura Tonnetti, Rebecca Townsend and Paul Losco!”
Title: Transfusion-transmitted babesiosis in the era of regional screening: Where are cases still emerging?
Authors: Rebecca Townsend, Paul Losco, Laura Tonnetti
Read the Full Article on Transfusion.
For more information see the gallery.
Stay updated featuring Courtney Lawrence on Hemostasis Today.
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden